a year ago
JNJ
AnalystsMorten HerholdtMorten Herholdt's Stock Forecasts
AnalystsMorten Herholdt
Analyst Ranking
Bottom 18%
#4022 out of 4871 analysts
Average Return
-5.56%
Win Rate
45%5 out of 11
Risk vs Reward
Poor
Good
Morten Herholdt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bluebird Bio IncBLUE | +86.26% | $27.80 | $3.82 | 2024-03-04 - 2025-03-04 | Sell |
Amgen IncAMGN | +30.26% | $249.01 | $324.36 | 2023-09-05 - 2024-09-05 | Strong Buy |
Iqvia Holdings IncIQV | +13.40% | $218.82 | $248.14 | 2023-09-05 - 2024-09-05 | Strong Buy |
Gilead Sciences IncGILD | +9.64% | $74.24 | $67.08 | 2023-09-05 - 2024-04-24 | Sell |
Johnson & JohnsonJNJ | +8.05% | $145.74 | $157.47 | 2024-04-17 - 2025-04-17 | Strong Buy |
Morten Herholdt Analyst Color
Get additional color on Morten Herholdt's coverage of popular stocks
2 years ago
JNJ
Morten Herholdt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zoetis IncZTS | 2 | Strong Buy | $225.00 | +42.91% | Maintains | a year ago |
Biogen IncBIIB | 2 | Strong Buy | $342.00 | N/A | Maintains | a year ago |
Gilead Sciences IncGILD | 2 | Hold | $69.00 | N/A | Upgrades | a year ago |
Johnson & JohnsonJNJ | 2 | Strong Buy | $170.00 | N/A | Upgrades | a year ago |
Bluebird Bio IncBLUE | 2 | Sell | $20.40 | N/A | Maintains | a year ago |
Labcorp Holdings IncLH | 1 | Hold | $210.00 | N/A | Initiates Coverage On | 2 years ago |
Unitedhealth Group IncUNH | 1 | Hold | $540.00 | N/A | Initiates Coverage On | 2 years ago |
Livanova PLCLIVN | 1 | Hold | $52.00 | N/A | Initiates Coverage On | 2 years ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $260.00 | N/A | Initiates Coverage On | 2 years ago |
Amgen IncAMGN | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 2 years ago |
Actinium Pharmaceuticals IncATNM | 1 | Strong Buy | $11.60 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.